A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors.
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Susan Domchek, MD
Abramson Cancer Center, University of Pennsylvania
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
47 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Bordeaux, France
- Research Site
Caen, France
- Research Site
Clermont-Ferrand, France
- Research Site
Dijon, France
- Research Site
Marseille, France
- Research Site
Nantes, France
- Research Site
Paris, France
- Research Site
Pierre Benit Cedex, France
- Research Site
Toulouse, France
- Research Site
Villejuif, France
- Research Site
Haifa, Israel
- Research Site
Jerusalem, Israel
- Research Site
Petah Tikva, Israel
- Research Site
Ramat Gan, Israel
- Research Site
Tel Aviv, Israel
- Research Site
Amsterdam, Netherlands
- Research Site
Amsterdam, Netherlands
- Research Site
Maastricht, Netherlands
- Research Site
Nijmegen, Netherlands
- Research Site
Rotterdam, Netherlands
- Research Site
Utrecht, Netherlands
- Research Site
Goyang-si, South Korea
- Research Site
Seongnam-si, South Korea
- Research Site
Seoul, South Korea
- Research Site
Seoul, South Korea
- Research Site
Seoul, South Korea
- Research Site
Seoul, South Korea
- Research Site
Seoul, South Korea
- Research Site
Seoul, South Korea
- Research Site
Chur, Switzerland
- Research Site
Lausanne, Switzerland
- Research Site
Cambridge, United Kingdom
- Research Site
Dundee, United Kingdom
- Research Site
Glasgow, United Kingdom
- Research Site
Greater London, United Kingdom
- Research Site
London, United Kingdom
- Research Site
London, United Kingdom
- Research Site
Manchester, United Kingdom
- Research Site
Newcastle upon Tyne, United Kingdom
- Research Site
Sutton, United Kingdom
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 17 Mar 2016
- Primary completion
- 17 Sept 2021
- Completion
- 17 Sept 2026
- Last update posted
- 20 Apr 2026
- Registered enrollment
- 264
- Registry id
- NCT02734004
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.